Conservative treatment of benign prostatic hyperplasia

References

• Clarke R. The prostate and endocrine. Br. J. Urol. 1937; 9: 254–2711. Clarke R. The prostate and endocrine. Br. J. Urol. 1937; 9: 254–271
   Google Scholar
• Deming C. L. The development of prostatic hyperplasias. Surg. Gynecol. Obstet. 1940; 70: 588–5942. Deming C. L. The development of prostatic hyperplasias. Surg. Gynecol. Obstet. 1940; 70: 588–594
   Google Scholar
• Deming C. L., Jenkins R. H., Van Wagenenen G. Further studies in the endocrinological relationships of prostatic hypertrophy. The effect of castration on the sub-urethral glands in the posterior urethra. J. Urol. 1935; 34: 678–6853. Deming C. L., Jenkins R. H., Van Wagenenen g. Further studies in the endocrinological relationships of prostatic hypertrophy. The effect of castration on the sub-urethral glands in the posterior urethra. J. Urol. 1935; 34: 678–685
   Google Scholar
• Guyen J. C. F. Leçons Cliniques sur les Maladies des Voies Urinaries. Baillere, Paris 19034. Guyen J. C. F. Leçons Cliniques sur les Maladies des Voies Urinaries. Baillere, Paris 1903
   Google Scholar
• Geller J., Angrist A., Nakao K., Newman H. Therapy with progestational agents in advanced benign prostatic hypertrophy. J.A.M.A. 1969; 210: 1421–14275. Geller J., Angrist A., Nakao K., Newman H. Therapy with progestational agents in advanced benign prostatic hypertrophy. J.A.M.A. 1969; 210: 1421–1427
   PubMed Web of Science ®Google Scholar
• Geller J., Bora R., Roberts T., Newman H., Lin A., Silva R. Treatment of benign prostatic hypertrophy with hydroxy-progesterone caproate. J.A.M.A. 1965; 193: 121–1286. Geller J., Bora R., Roberts T., Newman H., Lin A., Silva R. Treatment of benign prostatic hypertrophy with hydroxy-progesterone caproate. J.A.M.A. 1965; 193: 121–128
   PubMed Web of Science ®Google Scholar
• Huggins C. The etiology of benign prostatic hypertrophy. Bull. N.Y. Acad. Med. 1947; 23: 696–7047. Huggins C. The etiology of benign prostatic hypertrophy. Bull. N.Y. Acad. Med. 1947; 23: 696–704
   PubMedGoogle Scholar
• Huggins C, Stevens R. A. Effect of castration on benign hypertrophy of prostate in man. J. Urol. 1940; 43: 705–7148. Huggins C, Stevens R. A. Effect of castration on benign hypertrophy of prostate in man. J. Urol. 1940; 43: 705–714
   Google Scholar
• Huggins C, Webster W. O. Duality of human prostate in response to estrogen. J. Urol 1948; 59: 258–2669. Huggins C, Webster W. O. Duality of human prostate in response to estrogen. J. Urol 1948; 59: 258–266
   PubMed Web of Science ®Google Scholar
• Lebech P. E., Nordentoft E. L. A study of endocrine function in the treatment of benign prostatic hypertrophy with megestrol accrate. Acta Obstet. Gynecol. Scand. 1967; 46: 25–38, Suppl. 910. Lebech P. E., Nordentoft E. L. A study of endocrine function in the treatment of benign prostatic hypertrophy with megestrol accrate. Acta Obstet. Gynecol. Scand. 1967; 46: 25–38, Suppl. 9
   PubMed Web of Science ®Google Scholar
• Littleton P., Fotherby K., Dennis K. J. Metabolism of norgestrel in man. J. Endocrinol 1968; 42: 591–59811. Littleton P., Fotherby K., Dennis K. J. Metabolism of norgestrel in man. J. Endocrinol 1968; 42: 591–598
   PubMed Web of Science ®Google Scholar
• Lower W. E., McCullah. Summary of an experimental research on the control of benign prostatic hyperplasia and a preliminary clinical report. J. Urol 1935; 34: 670–67712. Lower W. E., McCullah. Summary of an experimental research on the control of benign prostatic hyperplasia and a preliminary clinical report. J. Urol 1935; 34: 670–677
   Google Scholar
• Moore R. A. Benign hypertrophy of the prostate. A morphological study. J. Urol 1943; 50: 680–71013. Moore R. A. Benign hypertrophy of the prostate. A morphological study. J. Urol 1943; 50: 680–710
   Google Scholar
• Moore R. A., McLellan A. M. A histological study of the sex hormones of the human prostate. J. Urol 1938; 40: 641–65714. Moore R. A., McLellan A. M. A histological study of the sex hormones of the human prostate. J. Urol 1938; 40: 641–657
   Google Scholar
• Palanca E. A. Thesurgical treatment of prostatic obstruction. Philipp. J. Surg. Spec 1968; 23(No. 6)15. Palanca E. A. Thesurgical treatment of prostatic obstruction. Philipp. J. Surg. Spec 1968; 23(No. 6)
   Google Scholar
• Scott W. W., Wade J. C. Medical treatment of benign nodular prostate hyperplasia with cyproterone acetate. J. Urol 1969; 101: 81–8516. Scott W. W., Wade J. C. Medical treatment of benign nodular prostate hyperplasia with cyproterone acetate. J. Urol 1969; 101: 81–85
   PubMed Web of Science ®Google Scholar
• Thumann R. C., Jnr. Estimation of weight of hyperplastic prostate from cystourethrography. Am. J. Roentgenol 1951; 65: 593–59517. Thumann R. C., Jnr. Estimation of weight of hyperplastic prostate from cystourethrography. Am. J. Roentgenol 1951; 65: 593–595
   Web of Science ®Google Scholar
• Weinberg S. R. Refractoriness of prostatism to hydroxy-progesterone caproate (Delalutin) therapy. J. Urol 1968; 100: 57–5818. Weinberg S. R. Refractoriness of prostatism to hydroxy-progesterone caproate (Delalutin) therapy. J. Urol 1968; 100: 57–58
   PubMedGoogle Scholar
• Wolfe H, Madsen P. O. Treatment of benign prostate hypertrophy with progestational agent - a preliminary report. J. Urol 1968; 99: 780–78519. Wolfe H, Madsen P. O. Treatment of benign prostate hypertrophy with progestational agent - a preliminary report. J. Urol 1968; 99: 780–785
   PubMed Web of Science ®Google Scholar